Buy Cipla with target of Rs 360, says VVLN Sastry

Buy Cipla with target of Rs 360, says VVLN Sastry, Firstcall India Equity.

Sastry told CNBC-TV18, "Pharmaceutical industry as a segment at this point of time is considered as a defensive segment for portfolio shifting and also seasonal sales for anti infectives due to the monsoon season are going to percentage wise increase the topline and bottomline."
He further added, "Cipla being an anti infectives major, definitely it is going to work well in favour of Cipla. So I feel that it is good to buy Cipla at this point of time with the target of Rs 360 and with a stop loss of Rs 315." Click HERE to know the rules and follow the score card